Why the study?
Malignant cardiac tumors are rare and highly malignant, necessitating improved clinical and pathological awareness and determination of interventions that can increase recurrence-free and overall survival.
This case highlights the rapid recurrence of cardiac undifferentiated pleomorphic sarcoma after surgical resection alone, suggesting a potential role for neoadjuvant therapy.
Answers are grounded in this paper and cite their sources.
Alerts clinicians to rare cardiac sarcomas in pregnancy; leaves open optimal interventions to improve survival.
Cardiac tumors are uncommon and most of them are benign. Although cases of malignant cardiac tumors are rare, it is still necessary to improve awareness in both clinical and pathological diagnosis. Since cardiac tumors often have a high degree of malignancy, it is vital to determine what form of intervention can increase recurrence-free survival and overall survival. In this paper, we report on a 42-year-old woman in the third trimester of pregnancy who had a cardiac undifferentiated pleomorphic sarcoma. According to her medical history, the patient had never had a cardiac tumor or any other disease. She was treated surgically and a left atrial mass was removed immediately after cesarean section. No other treatments were applied after the surgery, and, unfortunately, the tumor reoccurred 6 months later. We reviewed some literature and found one case in which the patient was treated using radiotherapy and survived for another 2 years after the third tumor recurrence. This suggests that neoadjuvant therapy effectively improves the survival rates of such patients.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: